Synsea Bio empowers Kesi Meishi to achieve new heights in performance, jointly building a benchmark for the transformation of "biological manufacturing+beauty"

Recently, COSMAX, a leading global beauty ODM company, released its 2025 performance announcement: its consolidated revenue for the year reached 2.3988 trillion Korean won (approximately 11.514 billion yuan), a year-on-year increase of 10.7%, setting a new historical high. In the Chinese market, Cosme Poetry also achieved a strong rebound, with annual sales increasing by 10.2% year-on-year to 632.7 billion Korean won (approximately RMB 3.33 billion).
Behind the steady growth of performance, Cosme is accelerating its transformation from traditional ODM to deep integration of "bio manufacturing+beauty", accurately anchoring the development trend of green and high-end beauty industry. As a core strategic partner, Xinhai Biotechnology, with its hardcore technology and industrialization capabilities in the field of high-value beauty raw material biomanufacturing, has made solid technological breakthroughs to help Kesi Meishi's performance growth and track upgrading build a solid technological foundation.